Clarke K W, Connelly D T, Charles R G
Cardiothoracic Centre, Liverpool, UK.
Heart. 1998 Oct;80(4):387-9. doi: 10.1136/hrt.80.4.387.
To determine the safety and cost effectiveness of single chamber atrial pacing in patients with sinus node disease.
Retrospective follow up study.
Tertiary referral centre.
81 patients with single chamber atrial pacemakers implanted between 1992 and 1996.
The development of high grade atrioventricular block resulting in a further pacemaker procedure. The cost savings of changing our current pacing practice to conform with British Pacing and Electrophysiology Group guidelines.
During the follow up period, four patients (5.8%) required a further procedure to upgrade their atrial pacemaker to a dual chamber system owing to the development of high grade atrioventricular block. In 1995 and 1996, 343 pacemakers were implanted in patients with sinus node disease; 19 (5.5%) received single chamber atrial pacemakers and 271 (79%) dual chamber pacemakers. If the current pacing practice was changed so that all patients received single chamber atrial pacemakers, with revision for symptomatic atrioventricular block, savings in excess of 206,000 Pounds would have been made in the two year period.
Atrial pacing in patients with sinus node disease is underused. The need for patients to undergo further procedures owing to the development of atrioventricular block is small and significant cost savings could be made by changing pacemaker practice.
确定单腔心房起搏在窦房结疾病患者中的安全性和成本效益。
回顾性随访研究。
三级转诊中心。
1992年至1996年间植入单腔心房起搏器的81例患者。
导致进一步起搏器植入手术的高度房室传导阻滞的发生情况。将我们目前的起搏实践改为符合英国起搏与电生理学会指南所节省的成本。
在随访期间,4例患者(5.8%)因发生高度房室传导阻滞而需要进一步手术将心房起搏器升级为双腔系统。1995年和1996年,343例窦房结疾病患者植入了起搏器;19例(5.5%)接受了单腔心房起搏器,271例(79%)接受了双腔起搏器。如果改变目前的起搏实践,使所有患者都接受单腔心房起搏器,并对有症状的房室传导阻滞进行修正,那么在两年内将节省超过206,000英镑。
窦房结疾病患者的心房起搏未得到充分利用。因房室传导阻滞发展而需要患者接受进一步手术的情况较少,改变起搏器实践可显著节省成本。